Argyrou Argyrides, Blanchard John S, Palfey Bruce A
Department of Biochemistry, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461, USA.
Biochemistry. 2002 Dec 10;41(49):14580-90. doi: 10.1021/bi020376k.
Lipoamide dehydrogenase catalyses the NAD(+)-dependent oxidation of the dihydrolipoyl cofactors that are covalently attached to the acyltransferase components of the pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, and glycine reductase multienzyme complexes. It contains a tightly, but noncovalently, bound FAD and a redox-active disulfide, which cycle between the oxidized and reduced forms during catalysis. The mechanism of reduction of the Mycobacterium tuberculosis lipoamide dehydrogenase by NADH and [4S-(2)H]-NADH was studied anaerobically at 4 degrees C and pH 7.5 by stopped-flow spectrophotometry. Three phases of enzyme reduction were observed. The first phase, characterized by a decrease in absorbance at 400-500 nm and an increase in absorbance at 550-700 nm, was fast (k(for) = 1260 s(-)(1), k(rev) = 590 s(-)(1)) and represents the formation of FADH(2).NAD(+), an intermediate that has never been observed before in any wild-type lipoamide dehydrogenase. A primary deuterium kinetic isotope effect [(D)(k(for) + k(rev)) approximately 4.2] was observed on this phase. The second phase, characterized by regain of the absorbance at 400-500 nm, loss of the 550-700 nm absorbance, and gain of 500-550 nm absorbance, was slower (k(obs) = 200 s(-)(1)). This phase represents the intramolecular transfer of electrons from FADH(2) to the redox-active disulfide to generate the anaerobically stable two-electron reduced enzyme, EH(2). The third phase, characterized by a decrease in absorbance at 400-550 nm, represents the formation of the four-electron reduced form of the enzyme, EH(4). The observed rate constant for this phase showed a decreasing NADH concentration dependence, and results from the slow (k(for) = 57 s(-)(1), k(rev) = 128 s(-)(1)) isomerization of EH(2) or slow release of NAD(+) before rapid NADH binding and reaction to form EH(4). The mechanism of oxidation of EH(2) by NAD(+) was also investigated under the same conditions. The 530 nm charge-transfer absorbance of EH(2) shifted to 600 nm upon NAD(+) binding in the dead time of mixing of the stopped-flow instrument and represents formation of the EH(2).NAD(+) complex. This was followed by two phases. The first phase (k(obs) = 750 s(-)(1)), characterized by a small decrease in absorbance at 435 and 458 nm, probably represents limited accumulation of FADH(2).NAD(+). The second phase was characterized by an increase in absorbance at 435 and 458 nm and a decrease in absorbance at 530 and 670 nm. The observed rate constant that describes this phase of approximately 115 s(-)(1) probably represents the overall rate of formation of E(ox) and NADH from EH(2) and NAD(+), and is largely determined by the slower rates of the coupled sequence of reactions preceding flavin oxidation.
硫辛酰胺脱氢酶催化与丙酮酸脱氢酶、α-酮戊二酸脱氢酶和甘氨酸还原酶多酶复合物的酰基转移酶组分共价连接的二氢硫辛酰辅因子的NAD⁺依赖性氧化。它含有一个紧密但非共价结合的FAD和一个氧化还原活性二硫键,在催化过程中它们在氧化态和还原态之间循环。通过停流分光光度法在4℃和pH 7.5条件下对结核分枝杆菌硫辛酰胺脱氢酶被NADH和[4S-(2)H]-NADH还原的机制进行了厌氧研究。观察到酶还原的三个阶段。第一阶段,其特征是400 - 500 nm处吸光度降低,550 - 700 nm处吸光度增加,速度很快(k₍f₎ = 1260 s⁻¹,k₍rev₎ = 590 s⁻¹),代表FADH₂·NAD⁺的形成,这是在任何野生型硫辛酰胺脱氢酶中从未观察到的一种中间体。在这个阶段观察到了初级氘动力学同位素效应[(D)(k₍f₎ + k₍rev₎)约为4.2]。第二阶段,其特征是400 - 500 nm处吸光度恢复,550 - 700 nm处吸光度损失,500 - 550 nm处吸光度增加,速度较慢(kₒbs = 200 s⁻¹)。这个阶段代表电子从FADH₂到氧化还原活性二硫键的分子内转移,以产生厌氧稳定的双电子还原酶EH₂。第三阶段,其特征是400 - 550 nm处吸光度降低,代表酶的四电子还原形式EH₄的形成。该阶段观察到的速率常数显示出对NADH浓度的依赖性降低,这是由于EH₂的缓慢异构化(k₍f₎ = 57 s⁻¹,k₍rev₎ = 128 s⁻¹)或在快速结合NADH并反应形成EH₄之前NAD⁺的缓慢释放导致的。在相同条件下也研究了NAD⁺氧化EH₂的机制。在停流仪器混合的死时间内,当NAD⁺结合时,EH₂的530 nm电荷转移吸光度移至600 nm,代表EH₂·NAD⁺复合物的形成。随后是两个阶段。第一阶段(kₒbs = 750 s⁻¹),其特征是435和458 nm处吸光度略有降低,可能代表FADH₂·NAD⁺的有限积累。第二阶段的特征是435和458 nm处吸光度增加,530和670 nm处吸光度降低。描述该阶段的观察到的速率常数约为115 s⁻¹,可能代表从EH₂和NAD⁺形成E(ox)和NADH的总速率,并且在很大程度上由黄素氧化之前的耦合反应序列的较慢速率决定。